These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19409669)

  • 21. HIV-1, HAART and bone metabolism.
    Borderi M; Farneti B; Tampellini L; Giuliani R; Verucchi G; Vescini F; Caudarella R; Chiodo F
    New Microbiol; 2002 Jul; 25(3):375-84. PubMed ID: 12173783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HAART-related nephropathies in HIV-infected patients.
    Daugas E; Rougier JP; Hill G
    Kidney Int; 2005 Feb; 67(2):393-403. PubMed ID: 15673287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.
    Gazzaruso C; Bruno R; Garzaniti A; Giordanetti S; Fratino P; Sacchi P; Filice G
    J Hypertens; 2003 Jul; 21(7):1377-82. PubMed ID: 12817187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
    Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of etravirine in combination antiretroviral therapy].
    Domingo P
    Enferm Infecc Microbiol Clin; 2009 Dec; 27 Suppl 2():46-51. PubMed ID: 20116628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
    Calza L; Manfredi R; Pocaterra D; Chiodo F
    J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative transcriptional profiling in HIV-infected patients using human stress arrays: clues to metabolic syndrome.
    Esposito V; Manente L; Viglietti R; Parrella G; Parrella R; Gargiulo M; Sangiovanni V; Perna A; Baldi A; De Luca A; Chirianni A
    In Vivo; 2012; 26(2):237-42. PubMed ID: 22351664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between highly active antiretroviral therapy and selected cardiovascular disease risk factors in sub-Saharan Africa: a systematic review and meta-analysis protocol.
    Dimala CA; Blencowe H
    BMJ Open; 2017 Mar; 7(3):e013353. PubMed ID: 28279997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study.
    Reinsch N; Buhr C; Krings P; Kaelsch H; Kahlert P; Konorza T; Neumann T; Erbel R;
    HIV Med; 2008 Aug; 9(7):550-6. PubMed ID: 18557952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations on the increase in blood pressure among antiretroviral-naive patients starting HAART.
    Martínez E; López Bernaldo de Quirós JC; Miralles C; Podzamczer D
    AIDS; 2007 Jan; 21(3):384-6. PubMed ID: 17255753
    [No Abstract]   [Full Text] [Related]  

  • 32. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003.
    Seaberg EC; Muñoz A; Lu M; Detels R; Margolick JB; Riddler SA; Williams CM; Phair JP;
    AIDS; 2005 Jun; 19(9):953-60. PubMed ID: 15905677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy.
    Dejkhamron P; Unachak K; Aurpibul L; Sirisanthana V
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):403-12. PubMed ID: 24259240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral therapy-associated diseases are common in the long-term.
    Lanzafame M; Lattuada E; Zoppini G; Vento S
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients.
    Rossi R; Nuzzo A; Guaraldi G; Squillace N; Orlando G; Esposito R; Lattanzi A; Modena MG
    Metabolism; 2009 Jul; 58(7):927-33. PubMed ID: 19394974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
    Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
    HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of body fat changes in mediating the effects of antiretroviral therapy on blood pressure in HIV-infected persons in a sub-Saharan African setting.
    Nduka CU; Uthman OA; Kimani PK; Malu AO; Stranges S
    Infect Dis Poverty; 2016 Jun; 5(1):55. PubMed ID: 27245216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment.
    Rose H; Woolley I; Hoy J; Dart A; Bryant B; Mijch A; Sviridov D
    Metabolism; 2006 Jan; 55(1):90-5. PubMed ID: 16324925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.